Hacer Karataş
West Virginia University(US)Istanbul Medipol University(TR)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Chemical Synthesis and Analysis, Hippo pathway signaling and YAP/TAZ, Cancer-related gene regulation
Most-Cited Works
- → Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia(2014)297 cited
- → In Vivo Molecular Bioluminescence Imaging: New Tools and Applications(2017)282 cited
- → High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein–Protein Interaction(2012)210 cited
- → Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction(2017)94 cited
- → The cholesterol transfer protein GRAMD1A regulates autophagosome biogenesis(2019)91 cited
- → Structure-Based Design of High-Affinity Macrocyclic Peptidomimetics to Block the Menin-Mixed Lineage Leukemia 1 (MLL1) Protein–Protein Interaction(2012)89 cited
- → TEAD–YAP Interaction Inhibitors and MDM2 Binders from DNA‐Encoded Indole‐Focused Ugi Peptidomimetics(2020)75 cited
- → MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency(2016)70 cited
- → Analysis of the Binding of Mixed Lineage Leukemia 1 (MLL1) and Histone 3 Peptides to WD Repeat Domain 5 (WDR5) for the Design of Inhibitors of the MLL1−WDR5 Interaction(2010)70 cited
- → Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket(2020)64 cited